Diagnostic News and Research

RSS

New plug-in optical sensor can help diagnose Kaposi's sarcoma

As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States.

5 Jun 2013

Clemson University, GHS partner to establish healthcare research powerhouse

Clemson University and Greenville Health System will establish a healthcare research powerhouse that will fuel growth in medical research and break-throughs, create opportunities for faculty, physicians and students and accelerate the flow of research funding into the Upstate, boosting the region's economy.

5 Jun 2013

seca releases medical Body Composition Analyzer

seca, the world's market leader in medical measuring and weighing, launches its medical Body Composition Analyzer, the seca mBCA 514.

From seca 4 Jun 2013

Diaxonhit, XDx agree to market and perform AlloMap Molecular Expression Testing in Europe

Diaxonhit, the leading French provider of specialty diagnostic solutions, and XDx, Inc., a U.S. molecular diagnostics company focused on non-invasive tests for transplantation and autoimmune disease, announced today that they have entered into a memorandum of agreement for the exclusive license to market and perform AlloMap Molecular Expression Testing (AlloMap) in Europe.

4 Jun 2013

Cardiovascular disease: The leading cause of death in UK

Cardiovascular disease is the leading cause of death in the UK, accounting for a third of all fatalities through illnesses such as stroke and heart disease.

4 Jun 2013

Early detection methods can help cure cervical cancer

Cervical cancer, a disease that will affect more than 12,000 women in the United States this year and more than a half million women worldwide, leads to significantly fewer deaths when effective early detection methods are available, either via a Pap smear or with a test for presence of the human papilloma virus.

4 Jun 2013

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer's disease cope better with the disease than individuals with a lower level of education in the same situation, according to research published in the June issue of The Journal of Nuclear Medicine.

4 Jun 2013

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.

4 Jun 2013

Gulf Coast Spine Care to use latest neck pain treatments to better meet the needs of patients

Gulf Coast Spine Care has been helping its patients treat their pain for many years, and recently the company has announced that they will be enacing a series of the latest neck pain treatments to better meet the needs of its patients.

4 Jun 2013

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

The criteria used to diagnose both circulatory and brain death in a patient are subject to variability and as such can be controversial. Anaesthesiologists play an important role in procedures related to the determination of death, so should have specific knowledge about medical, ethical and legal criteria of brain death definition.

3 Jun 2013

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from the combined data analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Arimidex, Tamoxifen, Alone or in Combination studies.

From NanoString Technologies 3 Jun 2013

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Activ8rlives’ website version 2.0 has now gone live after several months of preparation and testing. Activ8rlives focuses its online self monitoring solutions for health and wellness, which is utilized by families, groups and companies.

3 Jun 2013

Study investigates gene expression signature to predict response to bevacizumab

A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin-), according to new research from The University of Texas MD Anderson Cancer Center.

3 Jun 2013

Study shows utility of cfDNA blood tests for breast cancer patients

Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.

1 Jun 2013

FDA grants 510k clearance to muscle and joint rehabilitation medical device

The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.

1 Jun 2013

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.

From NanoString Technologies 1 Jun 2013

Viewpoints: Scalia's 'boost' to Obamacare; California small biz and insurance exchange; Health law's hidden tax

[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.

1 Jun 2013

Fujikura, Micro-Imaging Solutions to jointly co-market CMOS-based endoscopes

Fujikura Ltd and Micro-Imaging Solutions announced that they have entered into a license agreement to jointly co-market nano-sized, complementary metal-oxide semiconductor, or CMOS, based endoscopes.

1 Jun 2013

Mayo Clinic experts provide some insight about radiation dose from CT imaging

Many misconceptions exist about the risks associated with radiation doses and CT scans. Experts at Mayo Clinic want patients to have the right information about radiation dose, including when to have procedures with radiation, such as a CT scan, versus when to have magnetic resonance imaging or other non-radiation tests.

31 May 2013

Mayo Clinic introduces Individualized Medicine Clinic in Minnesota, Florida and Arizona

You have a serious medical condition, but the conventional tests fail to find an answer. You still have no diagnosis and no effective treatment. What do you do? Mayo Clinic has always been a destination for patients seeking answers. Now, Mayo is taking that concept to the next level with the public launch of its Individualized Medicine Clinic -- at all three of its campuses, in Minnesota, Florida and Arizona.

31 May 2013

Diagnostic News and Research

New plug-in optical sensor can help diagnose Kaposi's sarcoma

Clemson University, GHS partner to establish healthcare research powerhouse

seca releases medical Body Composition Analyzer

Diaxonhit, XDx agree to market and perform AlloMap Molecular Expression Testing in Europe

Cardiovascular disease: The leading cause of death in UK

Early detection methods can help cure cervical cancer

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Gulf Coast Spine Care to use latest neck pain treatments to better meet the needs of patients

Experts call for international consensus on criteria used to diagnose circulatory and neurological death

NanoString's Prosigna Breast Cancer Assay can help identify node-positive early-stage breast cancer

Activ8rlives 2.0 goes live with new self monitoring capabilities for health and wellness

Study investigates gene expression signature to predict response to bevacizumab

Study shows utility of cfDNA blood tests for breast cancer patients

FDA grants 510k clearance to muscle and joint rehabilitation medical device

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

Viewpoints: Scalia's 'boost' to Obamacare; California small biz and insurance exchange; Health law's hidden tax

Fujikura, Micro-Imaging Solutions to jointly co-market CMOS-based endoscopes

Mayo Clinic experts provide some insight about radiation dose from CT imaging

Mayo Clinic introduces Individualized Medicine Clinic in Minnesota, Florida and Arizona

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News